Voltage-gated sodium channel (neuronal subtypes) (NaV)

Voltage-gated sodium channels (NaVs) are essential transmembrane proteins that mediate the rapid influx of sodium ions required for the initiation and propagation of action potentials in neurons [PubMed: 25735992]. The primary neuronal subtypes include NaV1.1, NaV1.2, NaV1.3, and NaV1.6 in the central nervous system, and NaV1.7, NaV1.8, and NaV1.9 in the peripheral nervous system [PubMed: 22448031]. These channels consist of a large, pore-forming alpha subunit and associated beta subunits that modulate channel kinetics and trafficking. Mutations in the genes encoding these alpha subunits (SCN1A, SCN2A, SCN8A, SCN9A, etc.) are linked to a variety of neurological disorders, including Dravet syndrome, familial hemiplegic migraine, and various chronic pain syndromes [PubMed: 25735992]. Pharmacologically, these channels are the primary targets for local anesthetics, antiarrhythmics, and many anticonvulsant drugs, which typically act by stabilizing the inactivated state of the channel to limit repetitive firing [StatPearls: NBK537318]. Current research is heavily focused on developing subtype-selective inhibitors, particularly for NaV1.7 and NaV1.8, to provide effective analgesia without the central or cardiac side effects associated with non-selective sodium channel blockers [PubMed: 22448031]. Overall, neuronal NaVs represent a critical class of therapeutic targets for managing excitability-related disorders in both the central and peripheral nervous systems.

Other names

Sodium channel protein type 1 subunit alpha (SCN1A)Sodium channel protein type 2 subunit alpha (SCN2A)Sodium channel protein type 3 subunit alpha (SCN3A)Sodium channel protein type 8 subunit alpha (SCN8A)Sodium channel protein type 9 subunit alpha (SCN9A)Sodium channel protein type 10 subunit alpha (SCN10A)Sodium channel protein type 11 subunit alpha (SCN11A)Voltage-gated sodium channel alpha subunitVGSCNeuronal sodium channel

Voltage-dependent inhibition of the alpha subunit, primarily by binding to the local anesthetic receptor site and stabilizing the slow or fast inactivated states, which selectively suppresses high-frequency neuronal firing [PubMed: 25735992].